Teesside schools warning over vapes laced with Spice
Parents are being warned after a number of children were taken to hospital using vapes laced with the so-called zombie drug Spice.The students from Unity City Academy in Middlesbrough were admitted to James Cook University Hospital earlier this month, Cleveland Police said.Subsequent tests at a specialist laboratory revealed the presence of the synthetic cannabis substitute, which can have severe debilitating effects.All schools in Middlesbrough and Redcar and Cleveland are issuing letters to warn people not to use vapes which are sold via Snapchat and other social media apps.
It also urged people to treat any vape not purchased from a shop as suspicious and to report it immediately.Public health teams from both Middlesbrough Council and Redcar and Cleveland Borough Council are working with schools on providing advice, while teaching staff are being trained how to respond to incidents.The children who were taken to hospital "informed an adult as soon as they felt unwell", police said.They also issued a reminder that the legal age to purchase and use a vape is 18.
Follow BBC Tees on X, Facebook, Nextdoor and Instagram.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Reuters
a day ago
- Reuters
Texas health department reports no additional measles cases in the state since June 3
June 6 (Reuters) - The Texas health department reported no new cases of measles on Friday, the first time the state has not recorded an increase since the outbreak began in February. The state, which is the epicenter of the current measles outbreak, has a total of 742 confirmed cases as of Friday. The number of new cases continues to decrease, from an average of about 12 per day around the peak to fewer than one case per day recently, Chris Van Deusen, director of media relations at the Texas health department, told Reuters in an email. "The fact that (we) haven't had any new hospitalizations reported in more than two weeks gives us confidence there are not major numbers of unreported cases still occurring out there," said Van Deusen. The United States is battling one of the worst outbreaks of the highly contagious airborne infection it has seen, with over 1,000 reported cases and three confirmed deaths. Despite the slowing spread of the infection in Texas, the country continues to record weekly increases in measles cases elsewhere. The U.S. Centers for Disease Control and Prevention said a total of 1,168 confirmed measles cases were reported by 34 jurisdictions as of Thursday, an increase of 80 cases since its previous update last week. The only time infections surpassed the 1,000 mark was in 2019, when the country reported 1,274 cases. There have been 17 outbreaks, defined as three or more related cases, reported in 2025, the CDC said. Experts have urged public health officials to provide urgent endorsement for highly effective vaccines. The measles vaccine is 97% effective after two doses, according to the CDC.
BBC News
a day ago
- BBC News
Gonorrhoea vaccinations to start in Northern Ireland in August
The Department of Health has said a targeted vaccination programme against gonorrhoea has been approved across Northern Ireland. Eligible patients will be offered the vaccine from August 2025, the department said. Those eligible include gay and bisexual men who have a recent history of multiple sexual partners or have recently had a sexually transmitted infection (STI). Gonorrhoea is now the most prevalent STI diagnosed in sexual health clinics in Northern Ireland, according to the Public Health Agency (PHA). England will also begin its vaccination roll out in August this vaccine roll out will also focus mainly on gay and bisexual men with a history of multiple sexual partners or an was given by the Joint Committee on Vaccination and Immunisation (JCVI) in November 2023, which recommended roll out of the vaccine following an upsurge in gonorrhoea Minister Mike Nesbitt said the launch of the vaccine programme is "important and very timely for Northern Ireland's public health". He added that by targeting those "most at risk", there is an "opportunity to curb the spread and reduce transmission rates". The vaccine is an existing one for meningococcal B disease, called 4CMenB. The UK Health Security Agency (UKHSA) research shows that those who receive the jab could be protected from the STI by up to 40% and it could help tackle levels of antibiotic-resistant strains of the disease. Record number of gonorrhoea cases PHA figures for Northern Ireland show that between 2021 and 2022 the number of cases jumped from 652 to 1,606 - the highest number recorded by the were 951 cases in 2019, but that dropped to 455 in 2020, likely due to changes in behaviour and healthcare associated with the Covid 2023, there were 1,561 new cases, accounting for almost a third (28%) of all new STI diagnoses in Northern Ireland. Of those diagnosed, 75% were males and of those 67% were gay, bisexual and men who have sex with does not always have symptoms, but they can include pain, unusual discharge, inflammation of the genitals and infertility. The chief medical officer said the vaccine roll-out will have "significant public health benefits for both those who receive the vaccine, and the wider population".Sir Michael McBride said the programme has "the potential to result in less patients presenting with more complex cases and clusters of gonorrhoea".He encouraged all those eligible to take up the vaccine when offered. What is gonorrhoea? Gonorrhoea is easily passed from person to person through unprotected one in 10 infected men and almost half of infected women do not experience any infection can be passed from a pregnant woman to her baby, and without treatment, can cause permanent blindness for a newborn is not spread by non-sexual contact like is not transmitted through surfaces and materials like toilet seats, towels, cups or you have had successful treatment for gonorrhoea before, you can still catch it NHS.
The Independent
2 days ago
- The Independent
Who's in charge? CDC's leadership 'crisis' apparent amid new COVID-19 vaccine guidance
There was a notable absence last week when U.S. Health and Human Services Secretary Robert F. Kennedy Jr. announced in a 58-second video that the government would no longer endorse the COVID-19 vaccine for healthy children or pregnant women. The director of the Centers for Disease Control and Prevention — the person who typically signs off on federal vaccine recommendations — was nowhere to be seen. The CDC, a $9.2 billion-a-year agency tasked with reviewing life-saving vaccines, monitoring diseases and watching for budding threats to Americans' health, is without a clear leader. 'I've been disappointed that we haven't had an aggressive director since — February, March, April, May — fighting for the resources that CDC needs,' said Dr. Robert Redfield, who served as CDC director under the first Trump administration and supported Kennedy's nomination as the nation's health secretary. $9.2 billion-a-year agency without leader as nomination awaits The leadership vacuum at a foremost federal public health agency has existed for months, after President Donald Trump suddenly withdrew his first pick for CDC director in March. A hearing for his new nominee — the agency's former acting director Susan Monarez — has not been scheduled because she has not submitted all the paperwork necessary to proceed, according to a spokesman for Sen. Bill Cassidy, R-La., who will oversee the nomination. HHS did not answer written questions about Monarez's nomination, her current role at the CDC or her salary. An employee directory lists Monarez, a longtime government employee, as a staffer for the NIH under the Advanced Research Projects Agency for Health. Redfield described Kennedy as 'very supportive' of Monarez's nomination. Instead, a lawyer and political appointee with no medical experience is 'carrying out some of the duties' of director at the agency that for seven decades has been led by someone with a medical degree. Matthew Buzzelli, who is also the chief of staff at the CDC, is 'surrounded by highly qualified medical professionals and advisors to help fulfill these duties as appropriate,' Andrew Nixon, an HHS spokesperson said in a statement. Adding to the confusion was an employee-wide email sent last week that thanked 'new acting directors who shave stepped up to the plate." The email, signed by Monarez, listed her as the acting director. It was was sent just days after Kennedy said at a Senate hearing that Monarez had been replaced by Buzzelli. The lack of a confirmed director will be a problem if a public health emergency such as the COVID-19 pandemic or a rapid uptick in measles cases hits, said Michael Osterholm, an epidemiologist at the University of Minnesota. 'CDC is a crisis, waiting for a crisis to happen,' said Osterholm. 'At this point, I couldn't tell you for the life of me who was going to pull what trigger in a crisis situation." An acting director rarely seen, and stalled decisions At CDC headquarters in Atlanta, employees say Monarez was rarely heard from between late January – when she was appointed acting director – and late March, when Trump nominated her. She also has not held any of the 'all hands' meetings that were customary under previous CDC chiefs, according to several staffers. One employee, who insisted on anonymity because they were not authorized to speak to the media and fears being fired if identified said Monarez has been almost invisible since her nomination, adding that her absence has been cited by other leaders as an excuse for delaying action. The situation already has led to confusion. In April, a 15-member CDC advisory panel of outside experts met to discuss vaccine policy. The panel makes recommendations to the CDC Director, who routinely signs off on them. But it was unclear during the meeting who would be reviewing the panel's recommendations, which included the expansion of RSV vaccinations for adults and a new combination shot as another option to protect teens against meningitis. HHS officials said the recommendations were going to Buzzelli, but then weeks passed with no decision. A month after the meeting ended, the CDC posted on a web site that Kennedy had signed off on recommendations for travelers against chikungunya, a viral disease transmitted to humans by mosquitos. But there continues to be no word about a decision about the other vaccine recommendations. Controversial COVID-19 vaccine recommendations bypassed CDC panel The problem was accentuated again last week, when Kennedy rolled out recommendations for the COVID-19 vaccine saying they were no longer recommended for healthy children or pregnant women, even though expectant mothers are considered a high-risk group if they contract the virus. Kennedy made the surprise announcement without input from the CDC advisory panel that has historically made recommendations on the nation's vaccine schedule. The CDC days later posted revised guidance that said healthy kids and pregnant women may get the shots. Nixon, the HHS spokesman, said CDC staff were consulted on the recommendations, but would not provide staffer's names or titles. He also did not provide the specific data or research that Kennedy reviewed to reach his conclusion on the new COVID-19 recommendations, just weeks after he said that he did not think 'people should be taking medical advice' from him. 'As Secretary Kennedy said, there is a clear lack of data to support the repeat booster strategy in children,' Nixon said in a statement. Research shows that pregnant women are at higher risk of severe illness, mechanical ventilation and death, when they contract COVID-19 infections. During the height of the pandemic, deaths of women during pregnancy or shortly after childbirth soared to their highest level in 50 years. Vaccinations also have been recommended for pregnant women because it passes immunity to newborns who are too young for vaccines and also vulnerable to infections. Nixon did not address a written question about recommendations for pregnant women. Kennedy's decision to bypass the the advisory panel and announce new COVID-19 recommendations on his own prompted a key CDC official who works with the committee – Dr. Lakshmi Panagiotakopoulos – to announce her resignation last Friday. 'My career in public health and vaccinology started with a deep-seated desire to help the most vulnerable members of our population, and that is not something I am able to continue doing in this role,' she wrote in an email seen by an Associated Press reporter. Signs are mounting that the CDC has been 'sidelined' from key decision-making under Kennedy's watch, said Dr. Anand Parekh, the chief medical adviser for The Bipartisan Policy Center. 'It's difficult to ascertain how we will reverse the chronic disease epidemic or be prepared for myriad public health emergencies without a strong CDC and visible, empowered director,' Parekh said. 'It's also worth noting that every community in the country is served by a local or state public health department that depends on the scientific expertise of the CDC and the leadership of the CDC director.'
